Trial Profile
The multicenter randomized open controlled trials of impact on clinical effect and oxidative stress markers of Mucosta ophthalmic solution that targets the dry eye patients complicated with Sjogren's syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Mar 2018
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 16 Mar 2018 Status changed from active, no longer recruiting to completed.
- 13 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 15 Sep 2015 New trial record